HIV/AIDS Clinical Trials

An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).

Condition: HIV-1

NCT ID: NCT00359021

Kumasi Cohort Study

Condition: HIV

NCT ID: NCT01853657

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001094

Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI

Condition: HIV Infections

NCT ID: NCT00517192

A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Condition: HIV Infections

NCT ID: NCT00006152

A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Condition: Hepatitis C Virus Genotype-1

NCT ID: NCT01479868

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Condition: HIV Infection; Pulmonary TB

NCT ID: NCT00933790

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Condition: HIV Infections

NCT ID: NCT00001095

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Condition: HIV Infections

NCT ID: NCT00006326

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00028366

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

A Study of Amprenavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002405

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001087

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00440947

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Condition: Hepatitis C Infection; HIV Infection

NCT ID: NCT01185028

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00112047

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116415

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116116

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Condition: HIV Infection

NCT ID: NCT00244712

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT01384734

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098722

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098306

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

Condition: HIV Infections

NCT ID: NCT00028301

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring

Condition: HIV Infection

NCT ID: NCT01555723

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00071760

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00849160

Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice

Condition: HIV Infections

NCT ID: NCT01375881

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00075907

Optimizing Treatment for Treatment-Experienced, HIV-infected People

Condition: HIV Infections

NCT ID: NCT00537394

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

Expanded Access Program for Maraviroc At Multiple Centers

Condition: Advanced HIV Infection

NCT ID: NCT00426660

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Condition: HIV Infections

NCT ID: NCT00207142

A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals

Condition: HIV Infections; Neurosyphilis

NCT ID: NCT00000648

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1

Condition: HIV-1

NCT ID: NCT01345630

Telephone Support to Improve Adherence to Anti-HIV Medications

Condition: HIV Infections

NCT ID: NCT00988442

Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda

Condition: HIV-infection/Aids

NCT ID: NCT01140633

Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay

Condition: HIV Infections

NCT ID: NCT00496782

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

Condition: HIV Infections; Peripheral Nervous System Disease

NCT ID: NCT00000817

Kaletra and Viread in Antiretroviral Naïve Patients

Condition: HIV Infections

NCT ID: NCT00679926

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00016718

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00002301

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Condition: HIV Seropositivity; HIV Infection

NCT ID: NCT00035581

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Condition: HIV Infections; Human Immunodeficiency Virus

NCT ID: NCT00299897

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT00089583

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01102972

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

Condition: Acquired Immune Deficiency Syndrome; AIDS; Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00814879

The VMVN Study: Virological Monitoring in Viet Nam

Condition: HIV Infection; AIDS

NCT ID: NCT01317498

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00946595

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Condition: HIV Infections

NCT ID: NCT00654147

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Condition: HIV Infections

NCT ID: NCT00120783

Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study

Condition: HIV Infection; Adverse Drug Reaction; Quality of Life

NCT ID: NCT01679964

Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

Condition: HIV Infections

NCT ID: NCT01066962

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01332955

Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS

Condition: HIV-1 Infection

NCT ID: NCT01435018

Not yet recruiting

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00299338

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Condition: HIV Infections; Hepatitis C, Chronic

NCT ID: NCT00122616

3TC or No 3TC for HIV With 3TC Resistance

Condition: HIV Infections

NCT ID: NCT00143728

Suspended

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

Condition: HIV Infections

NCT ID: NCT01272258

BASTA Study on STI in HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00310245

Clinic-based ART Diagnostic Evaluation

Condition: Acquired Immunodeficiency Syndrome; HIV Infection; RNA Virus Infections; Virus Diseases

NCT ID: NCT01791556

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Condition: HIV Infections

NCT ID: NCT00160849

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Condition: Human Immunodeficiency Virus

NCT ID: NCT00051844

Extending HIV Care Beyond the Rural Health Center

Condition: HIV; HIV Infections

NCT ID: NCT00371540

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00297076

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00197145

Switching From PI to RALtegravir in HIV Stable Patients

Condition: HIV Infections

NCT ID: NCT00528892

Comparative Study of Three NNRTI-Sparing HAART Regimens

Condition: HIV Infection

NCT ID: NCT00811954

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT00698334

Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs

Condition: HIV Infections

NCT ID: NCT00477308

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Condition: HIV Infections

NCT ID: NCT00038480

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00051090

Withdrawn(En español)

Durability of Adherence in Self-Management of HIV (The DASH Study)

Condition: HIV Infections

NCT ID: NCT00991302

Recruiting(En español)

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00389207

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients

Condition: HIV Infections

NCT ID: NCT00677300

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients

Condition: Chronic Infection With HIV

NCT ID: NCT01829802

Not yet recruiting

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Condition: HIV

NCT ID: NCT01423812

Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00004986

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00766597

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Condition: HIV Infections

NCT ID: NCT00447902

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Condition: HIV Infections

NCT ID: NCT00440271

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00017719

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Condition: HIV Infections

NCT ID: NCT00421551

Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria

Condition: HIV Infections; Proteinuria

NCT ID: NCT01044771

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00993148

Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00352053

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

Condition: HIV Infections

NCT ID: NCT00162682

The Detection of Drug-Resistant HIV-1 in Taiwan

Condition: HIV Infections

NCT ID: NCT00690001

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Condition: HIV Infections

NCT ID: NCT00460382

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00135460

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

Condition: HIV Infections

NCT ID: NCT00001045

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment

Condition: HIV Infections

NCT ID: NCT00544128

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122590

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Condition: HCV Coinfection; HIV-1 Infection

NCT ID: NCT01335529

Immune and Viral Outcomes of HIV-1 Therapy Interruption

Condition: HIV Infections

NCT ID: NCT00051818

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00966160

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00257621

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00822315

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00646984

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Condition: HIV Infections

NCT ID: NCT00084058

Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01568892

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Condition: Chronic Hepatitis C

NCT ID: NCT01513941

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

Condition: HIV-1 Infection

NCT ID: NCT01714414

Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen

Condition: HIV-1 Infection

NCT ID: NCT01400412

Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya

Condition: HIV; Malnutrition

NCT ID: NCT01548599

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

Condition: HIV Infections

NCT ID: NCT00959894

Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive

Condition: HIV-1 Infection

NCT ID: NCT01489046

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Condition: HIV Infections

NCT ID: NCT00000903

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

Condition: HIV Infection

NCT ID: NCT00040664

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

Condition: HIV Infections

NCT ID: NCT00552240

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Condition: HIV Infections

NCT ID: NCT00659789

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Condition: HIV-1 Infection

NCT ID: NCT01772940

"The Once A Day Protease Inhibitor Regimens"

Condition: HIV Infections; Antiretroviral Therapy

NCT ID: NCT00242216

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000796

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01499199

Promoting Adherence to Anti-HIV Drug Regimens

Condition: HIV Infections

NCT ID: NCT00051805

ALCAR Prophylaxis Study

Condition: HIV Infections; Distal Symmetric Polyneuropathy

NCT ID: NCT00225160

Atazanavir for HIV Infected Individuals: An Early Access Program

Condition: HIV Infections

NCT ID: NCT00046345

No longer available

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

Condition: HIV-1

NCT ID: NCT00824421

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Condition: HIV Infections

NCT ID: NCT00642291

Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada

Condition: HIV-1

NCT ID: NCT00324649

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment

Condition: HIV

NCT ID: NCT00757783

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Condition: HCV Coinfection; HIV Infection

NCT ID: NCT01529073

Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00144157

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Condition: HIV-1 Infection

NCT ID: NCT01338883

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

Condition: HIV

NCT ID: NCT01620944

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT00449436

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Condition: HIV Infections

NCT ID: NCT00145795

Antiretroviral Therapy and Extreme Weight

Condition: HIV Infection

NCT ID: NCT01805427

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Condition: HIV

NCT ID: NCT01275625

Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring

Condition: Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00836212

Pediatric Nevirapine Resistance Study

Condition: AIDS; HIV Infections

NCT ID: NCT00117728

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01105611

NOW Thai HAART Study

Condition: HIV; AIDS; Neurological Complications

NCT ID: NCT00367731

Evaluation of Patients Who Have Not Had Success With Zidovudine

Condition: HIV Infections

NCT ID: NCT00001025

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01641809

Surveillance of Kaletra in Korean Patients

Condition: HIV-1 Infection

NCT ID: NCT01083173

Enrolling by invitation

A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)

Condition: HIV Infections

NCT ID: NCT00002279

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT00827112

Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1) (Study P03672AM6)

Condition: HIV Infections

NCT ID: NCT00243230

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Condition: HIV-1

NCT ID: NCT00665847

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Condition: HIV Infection

NCT ID: NCT00158470

Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment

Condition: HIV Infections

NCT ID: NCT00751153

Rifampin and Efavirenz Interactions in Older Children

Condition: HIV; Tuberculosis

NCT ID: NCT01704144

Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children

Condition: Acute Otitis Media

NCT ID: NCT01031082

Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression

Condition: HIV-1 Infection

NCT ID: NCT01511809

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Condition: HIV

NCT ID: NCT00335270

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000695

Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients

Condition: Mitochondrial Toxicity; Metabolic Complications

NCT ID: NCT01601899

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00082498

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Condition: Lung Cancer

NCT ID: NCT00276588

Tuberculosis Treatment Shortening Trial

Condition: Tuberculosis

NCT ID: NCT00130247

Comparison of Facility and Home-based ART Delivery Systems in Uganda

Condition: AIDS

NCT ID: NCT00144365

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Condition: AIDS

NCT ID: NCT00207168

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Condition: Cancer

NCT ID: NCT01316744